Relapsed/refractory (R/R) mature B cell non Hodgkin lymphoma (NHL)

Clinical trials for Relapsed/refractory (R/R) mature B cell non Hodgkin lymphoma (NHL) explained in plain language.

Never miss a new study

Get alerted when new Relapsed/refractory (R/R) mature B cell non Hodgkin lymphoma (NHL) trials appear

Sign up with your email to follow new studies for Relapsed/refractory (R/R) mature B cell non Hodgkin lymphoma (NHL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New pill targets Hard-to-Treat lymphoma in first human trial

Disease control Recruiting now

This early-stage trial tests an experimental drug called ARV-393 in 255 adults with advanced non-Hodgkin's lymphoma that has come back or not responded to other treatments. The drug is taken as a pill and works by breaking down a protein that helps lymphoma grow. The main goals a…

Matched conditions: RELAPSED/REFRACTORY (R/R) MATURE B CELL NON HODGKIN LYMPHOMA (NHL)

Phase 1 • Sponsor: Arvinas Inc. • Aim: Disease control

Last updated Sep 06, 2026 00:00 UTC

Relapsed/refractory (R/R) mature B cell non Hodgkin lymphoma (NHL)

Get alerted when new Relapsed/refractory (R/R) mature B cell non Hodgkin lymphoma (NHL) trials appear

New pill targets Hard-to-Treat lymphoma in first human trial